These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8363235)

  • 1. Immunosuppressive activity of mycophenolate mofetil.
    Eugui EM; Allison AC
    Ann N Y Acad Sci; 1993 Jun; 685():309-29. PubMed ID: 8363235
    [No Abstract]   [Full Text] [Related]  

  • 2. The design and development of an immunosuppressive drug, mycophenolate mofetil.
    Allison AC; Eugui EM
    Springer Semin Immunopathol; 1993; 14(4):353-80. PubMed ID: 8322167
    [No Abstract]   [Full Text] [Related]  

  • 3. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil for transplantation: new drug, old problems?
    Gray DW
    Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of action of mycophenolic acid.
    Allison AC; Kowalski WJ; Muller CD; Eugui EM
    Ann N Y Acad Sci; 1993 Nov; 696():63-87. PubMed ID: 7906496
    [No Abstract]   [Full Text] [Related]  

  • 6. Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation.
    Allison AC; Eugui EM
    Transplant Proc; 1994 Dec; 26(6):3205-10. PubMed ID: 7998117
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil.
    Allison AC; Eugui EM
    Immunol Rev; 1993 Dec; 136():5-28. PubMed ID: 7907572
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil and its mechanisms of action.
    Allison AC; Eugui EM
    Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.
    Smak Gregoor PJ; van Gelder T; Weimar W
    Neth J Med; 2000 Dec; 57(6):233-46. PubMed ID: 11099793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil.
    Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
    Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of mycophenolate mofetil in pediatric renal transplantation.
    Tönshoff B
    Pediatr Transplant; 1999 Feb; 3(1):5-9. PubMed ID: 10359025
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443.
    Allison AC; Almquist SJ; Muller CD; Eugui EM
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):10-4. PubMed ID: 2063415
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
    Fulton B; Markham A
    Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil and brequinar sodium: new immunosuppressive agents.
    Hullett DA; Sollinger HW
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):45-7. PubMed ID: 8516943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.
    Hutchinson P; Jose M; Atkins RC; Holdsworth SR
    Transpl Immunol; 2004; 13(1):55-61. PubMed ID: 15203129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
    Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
    Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].
    Sánchez-Fructuoso AI
    Nefrologia; 2005; 25(3):234-42, 244. PubMed ID: 16053004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.